Kimberly-Clark enters the post-earnings stretch with short sellers rebuilding positions, insiders selling into strength, and analysts largely on the sidelines — a setup that leaves the stock with limited near-term catalysts to test the consensus price target gap.
The most notable development this week is the rebound in short interest following Q1 results. Shorts dropped sharply between April 21 and April 24 — from roughly 13% of free float to 11.7% — as sellers covered ahead of or into the print. That partial cover proved short-lived. By April 28, SI had climbed back to 12.2% of free float, recovering most of the ground given up during the result week. The short score reinforces the picture: it ran at 66.5 on April 20, dipped to 63.2 on April 24, and has since recovered to 64.9. Borrow conditions remain relaxed. Cost to borrow is a negligible 0.45%, down 16% over the past month, and availability is loose — nothing in the lending market signals a squeeze. Options are similarly muted: the put/call ratio is 0.562, only marginally above its 20-day average of 0.545, and well inside the 52-week range of 0.34 to 0.84. Shorts are rebuilding, but cautiously, and with no urgency from the borrow market.
The Street's response to Q1 tells a similar story of contained expectations. UBS raised its target modestly to $106 — while holding a Neutral — the morning of April 29, a small positive tweak that barely moves the needle. Most of the recent action has been in the other direction: Barclays cut its target to $99 from $105 earlier in the month, and Wells Fargo trimmed to $100 from $110 in early April. The consensus mean price target runs at $114.50, which implies roughly 19% upside from the current $96.10. That gap is real, but the direction of travel on targets has been down, not up. B of A Securities holds the most constructive view — a Buy with a $120 target — but even that was cut from $130 in April. Factor scores confirm the mixed picture: EPS momentum over 30 days is a weak 25th percentile. EPS momentum over 90 days improves to 43rd percentile. The only standout is a dividend score at the 90th percentile, reflecting the stock's appeal to income-focused holders — though note the dividend history in the data is stale and the exact yield should be verified independently.
The insider picture is genuinely worth flagging. On April 24 — the day stock was awarded as part of compensation — CEO Michael Hsu and several other executives immediately sold. Hsu himself disposed of around 35,000 shares for approximately $3.46 million. CFO Nelson Urdaneta sold 1,333 shares at $97.85. A division president sold over 8,000 shares worth $815,000. The net 90-day insider position is positive at roughly 77,000 shares, but that reflects accumulated awards. The open-market activity on the sell side, clustered on a single day immediately after grant, is a routine compensation event rather than a conviction trade — but it does add to the supply picture at a moment when the stock is already under pressure.
Earnings land again on May 14. The Q1 result itself produced a 2.2% drop on the day — consistent with the previous print from January, which also saw a modest negative 1-day move. The stock has given back 2.6% over the past month and is down 0.7% on the week, underperforming close peers PG and CL, which each gained around 2.5% over the same seven days. CLX fell 2.1% on the week, closer to KMB's experience, suggesting the sector broadly is navigating some near-term headwinds — though the degree of divergence within it is notable.
With the Q1 result now absorbed, attention turns to whether the May 14 call shifts the narrative on North American volume trends. The bear case centres on deteriorating retail sales momentum and downward revisions to EPS estimates — FY2026 EPS projections have been nudged lower to around $7.85. The bull case rests on brand strength, international diversification, and potential cost synergies from the Kenvue acquisition integration. The short position is large enough — over 12% of free float — to matter if either side gets a decisive catalyst. For now, positioning looks structurally cautious rather than acutely stressed: shorts are present but not crowding, borrow is cheap, and the options market is not pricing in a big swing.
See the live data behind this article on ORTEX.
Open KMB on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
